Zanidatamab (ZW25; Zani) in patients (pts) with previously treated advanced human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC): Asia subgroup analysis of the phase IIb HERIZON-BTC-01 study

H. Sun,J. W. Kim,H. J. Choi,H-M. Chang, L. Bao,J. Ying, F. Xie,M. A. Lee, K. Dong Uk, T. Song, H. Pan, G. Yu,K. Li, Q. Yan, X. Wu, Y. Bao, P. Garfin, J. Ma, J. Fan,D-Y. Oh

ANNALS OF ONCOLOGY（2023）

Cited 0|Views8

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined